clinical trials

News

Bayer reveals data behind asundexian's stroke win

Bayer's oral Factor XIa inhibitor asundexian can reduce the risk of a secondary ischaemic stroke by 26%, according to the OCEANIC-STROKE trial.

News

Novo Nordisk's CagriSema tops Ozempic in diabetes trial

Novo Nordisk is considering filing CagriSema for diabetes, in addition to obesity, after it outperformed Ozempic in a head-to-head study.

News

Mixed data mars Sanofi's venglustat programme

Sanofi has reported positive phase 3 results with venglustat in Gauder disease, but the drug missed the mark in a Fabry disease trial.

News

Bottle of Tavneos with two pills in front of it

EMA looks into 'data integrity' issue with Amgen's Tavneos

Concerns about efficacy data in the main trial behind the approvals of Amgen and CSL Vifor's Tavneos have triggered a review in the EU.

News

Boehringer drug scores in rare kidney disease FSGS

Boehringer's TRPC6 inhibitor apecotrep, formerly developed for COVID-19, has shown efficacy in the rare kidney disease FSGS in a phase 2 trial.

News

Roche claims midstage win for obesity injectable

Roche reports weight loss of up to 22.5% with its injectable GIP/GLP-1 agonist obesity drug, setting up phase 3, but will it be too late to the table?

Bayer reveals data behind asundexian's stroke win

Novo Nordisk's CagriSema tops Ozempic in diabetes trial

Mixed data mars Sanofi's venglustat programme

EMA looks into 'data integrity' issue with Amgen's Tavneos

Boehringer drug scores in rare kidney disease FSGS

Roche claims midstage win for obesity injectable

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

clinical trials

Editor's Picks